


Find new investment opportunities based on Market Sentiment Indicator. Manage watchlist risk with leading indicator of volatility See what influential analysts and investors are saying about stocks in My Watchlist
Most Trending
+11.78%
-6.36%
+3.34%
+6.85%
UTHR
United Therapeutics Corpo
$469.49
Strengths

Earnings are forecast to grow

Upgraded on attractively valued
UTHR Price Performance
$487.25 (-3.64%)
$438.66 (+7.03%)
$400.52 (+17.22%)
$370.44 (+26.74%)
Overall standing based on market and analyst consensus.
Hover over the category for more information
Earnings
Earnings
Rating
Rating

Upgraded on attractively valued
Momentum
Momentum
Activity
Activity
Future
Future

Earnings are forecast to grow
![]()
UTHR Analysts opinion is negative and it remained unchanged from the past 3 months
Analysts perspectives on the stock desirability, trend direction and growth potential
UTHR Street Sentiment is extremely bullish and have positive views on the near-term outlook
UTHR has Low risk level
Risks Indicators

Low volume

Average key support and resistance price levels
Recent Upgrades and Downgrades
STRONG BUY
Date
Action
Rating
Firm
Nov 07, 2025
Reiterate
Buy
UBS
Oct 16, 2025
Reiterate
its Buy
Jefferies
Sep 29, 2025
Reiterate
Buy
UBS
Sep 26, 2025
Initiate
Outperform
RBC
What is UTHR current stock price?
What are UTHR stock strengths?
What is UTHR Risk Level?
What is UTHR market cap and volume?
What is UTHR current Stock IQ?
Should I buy UTHR stock right now?
Is UTHR a Strong Buy right now?
What does a 'Strong Buy' rating mean for UTHR?
What does a 'Strong Sell' rating mean for UTHR?
What factors influence UTHR's Stock IQ?
Join over 10,000+ subscribers who value exclusive insights. Stay ahead in the stock market! Enter your email for daily alerts
Stay ahead of the market
Market trends
Investment tips
Market analysis service
Future potential
Informed investment decisions
Investment analysis
IInvestment strategies
In-depth stock analysis
Performance analysis
Stock market insights
Financial trends analysis
Most Trending
+11.78%
-6.36%
+3.34%
+6.85%
UTHR
United Therapeutics Corpo
Current Price
$469.49
Stock Insights
Strengths

Earnings are forecast to grow

Upgraded on attractively valued

UTHR Price Performance
$487.25 (-3.64%)
$438.66 (+7.03%)
$400.52 (+17.22%)
$370.44 (+26.74%)
UTHR Analysts Opinion
Overall standing per market and analyst expectations.
Hover over the category for more information
Earnings
Earnings
Rating
Rating

Upgraded on attractively valued
Momentum
Momentum
Activity
Activity
Future
Future

Earnings are forecast to grow
![]()
UTHR Analysts opinion is negative and it remained unchanged from the past 3 months
Analysts perspectives on the stock desirability, trend direction and growth potential
UTHR Street Sentiment is extremely bullish and have positive views on the near-term outlook
UTHR has Low risk level
Risks Indicators

Low volume

Average key support and resistance price levels
Overall Wall Street Rating
STRONG BUY
Nov 07, 2025
Reiterate
Buy
UBS
Oct 16, 2025
Reiterate
its Buy
Jefferies
Sep 29, 2025
Reiterate
Buy
UBS
Sep 26, 2025
Initiate
Outperform
RBC
UTHR Stock IQ
UTHR Latest Analysis
United Therapeutics Reports Early Success For External Liver Support In Acute Failure. ) on Monday shared results from its phase 1 study of miroliverELAP an external liver assist product in patients with .Developed by ELAP consists of an external blood circuit and a single-use bioengineered liver sustained outside of the human body to provide temporary liver support to patients.The bioengineered liver is manufactured by seeding a decellularized porcine liver scaffold with allogeneic human endoth
Mon Jan 26, 2026
Why United Therapeutics (UTHR) is a Top Growth Stock for the Long-Term. The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Heres why you should take advantage.
Fri Jan 16, 2026
Heres Why United Therapeutics (UTHR) is a Strong Value Stock. Whether youre a value growth or momentum investor finding strong stocks becomes easier with the Zacks Style Scores a top feature of the Zacks Premium research service.
Thu Jan 15, 2026
United Therapeutics Corporation (UTHR) Presents at 44th Annual J.P. Morgan Healthcare Conference Transcript.
Tue Jan 13, 2026
FIND US ON
Unlock the knowledge that 10,000+ subscribers already cherish. Join for exclusive insights and stay ahead in the stock game! Enter your email to receive daily alerts
In-depth stock analysis
Informed investment decisions
Stock market insights
Stock trading tips
UTHR Stock trends
UTHR Stock performance
UTHR Stock analysis
UTHR investment strategies
Disclaimer:
Past performance, whether from actual results or historical strategy tests, does not guarantee future success. The displayed outcomes are based on strategies not previously available to investors and do not depict the returns achieved by any specific investor.
The Readiness Indicators, Sentiment Indicators and overall score are derived from a model retrospectively applied using historical data. This model relies on assumptions inherent to it, which may or may not be verifiable and carry potential risks, including losses.
Engaging in active trading may not be suitable for individuals with limited resources, minimal investment or trading experience, or a low-risk tolerance. Proceed with caution as your capital is exposed to risks.
Please note that no offer or solicitation to buy or sell securities, securities derivatives of future products of any kind, or any type of trading or invesment advise, recommendation or strategy, is made, given or endorsed by StocksRunner including any of their affiliates ("TS").
This information is provided for illustrative purposes only. You should not rely on any advice and/or information contained in this website and before making any investment decision. we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice.